Metformin Tied to Better Clinical Outcomes in CKD, CHF, CLD

Share this content:
Metformin Tied to Better Clinical Outcomes in CKD, CHF, CLD
Metformin Tied to Better Clinical Outcomes in CKD, CHF, CLD

WEDNESDAY, Jan. 4, 2017 (HealthDay News) -- For patients with chronic kidney disease (CKD), congestive heart failure (CHF), or chronic liver disease (CLD) with hepatic impairment, metformin use is associated with improvements in clinical outcomes, according to a review published online Jan. 3 in the Annals of Internal Medicine.

Matthew J. Crowley, M.D., from the Durham Veterans Affairs Medical Center and Duke University School of Medicine in North Carolina, and colleagues synthesized data addressing outcomes of metformin use in patients with type 2 diabetes and moderate to severe CKD, CHF, or CLD with hepatic impairment. Data were included from studies that compared diabetes regimens that included metformin with those that did not, and reported all-cause mortality, major adverse cardiovascular events, and other outcomes of interest.

The researchers found that metformin use correlated with reduced all-cause mortality in patients with CKD, CHF, or CLD with hepatic involvement on the basis of quantitative and qualitative syntheses involving 17 observational studies. In patients with CKD or CHF, metformin use correlated with fewer heart failure readmissions.

"Metformin use in patients with moderate CKD, CHF, or CLD with hepatic impairment is associated with improvements in key clinical outcomes," the authors write. "Our findings support the recent changes in metformin labeling."

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Pediatricians Should Provide Sexual Health Care Services

Pediatricians Should Provide Sexual Health Care Services

Office visits present opportunity to provide comprehensive education and health care services

Guidelines Updated for Infection Prevention in Pediatrics

Guidelines Updated for Infection Prevention in Pediatrics

Update focused on key principles of infection prevention, control relevant to ambulatory patients

2003 to 2014 Saw Drop in Urinary Arsenic in Public Water Users

2003 to 2014 Saw Drop in Urinary Arsenic ...

Reduction occurred after implementation of EPA's maximum contaminant level for arsenic

is free, fast, and customized just for you!

Already a member?

Sign In Now »